New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events: You Weigh the Evidence

Hear from 2 expert faculty who will address the complex interrelationships involved in atherosclerotic cardiovascular disease.
Hear from 2 expert faculty who will address the complex interrelationships involved in atherosclerotic cardiovascular disease.
Enroll in this meeting
September 25, 2019
06:00 PM - 08:00 PM EDT
Loews Philadelphia Hotel
1200 Market Street, Regency B Ballroom, Philadelphia, Pennsylvania, United States
Enrollment Fee: Free
Free
  • Overview

    This 90-minute, CME-certified symposium will feature a faculty of 2 leading international experts who will address the complex interrelationships involved in atherosclerotic cardiovascular disease (ASCVD) risk. The educational activity will provide an opportunity for symposium participants to understand how to apply the recent 2018 AHA/ACC Guideline on the Management of Blood Cholesterol to patient care, appreciate the spectrum of major recent ASCVD randomized cardiovascular outcomes trials including the role of prescription omega-3 fatty acids to impact ASCVD events, and work through complex issues that challenge healthcare providers in caring for patients with or at high-risk of ASCVD, many of whom have been sub-optimally managed. The expert faculty will interactively present case-based scenarios that require use of guidelines and evidence on managing ASCVD risk beyond first-line statin therapy to optimize risk reduction strategies and patient outcomes.

    This event is not part of the official AAFP FMX.

  • Learning Objectives

    After completing this activity, the participant should be better able to:

    • Have greater clarity on implementing the new 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
    • Describe the spectrum of major recent ASCVD randomized cardiovascular outcomes trials
    • Appreciate the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
    • Apply evidence-based guidelines and recent randomized clinical trial evidence to lifestyle and therapeutic approaches for managing patients at high risk of cardiovascular events
  • Agenda

    6:00 pm–6:30 pm             

    Registration &  Buffet Dinner

     

     

    6:30 pm–6:40 pm

    Welcome, Introductions, Program Overview, and Pre-Activity Test Questions

     

     

    6:40 pm–6:55 pm

    New Cholesterol Guidelines: What You Should Know

     

     

    6:55 pm–7:15 pm

    Update on Cardiovascular Outcomes Trials of Adjunctive Therapies to Statins

     

     

    7:15 pm–7:30 pm

    Personalizing Management of ASCVD Risk Factors

     

     

    7:30 pm–7:45 pm

    Case Presentations on ASCVD Prevention

     

     

    7:45 pm–7:55 pm

    Panel Discussion and Question & Answers

     

     

    7:55 pm–8:00 pm

    Post-activity test questions, Closing Comments

  • Target Audience

    This activity is intended for family practice physicians, nurses, and pharmacists and allied healthcare professionals engaged in the care of patients with or at high risk of ASCVD.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Commercial Support

    This activity is supported by an independent educational grant from Amarin Pharma, Inc.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

  • American Disabilities Act

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jessica McGrory prior to the live event at jmcgrory@omnia-prova.com.

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free